A clinico-pathological study of subtypes in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Brain : a journal of neurology

• Publication date

  2009-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/awp234PMID 19759203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Sydney Multicenter Study of Parkinson's Disease: The Inevitability of Dementia at 20 years

  2009cited by this paper
• Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening

  2008cited by this paper
• Dementia and survival in Parkinson disease

  2008cited by this paper
• Clinical heterogeneity in newly diagnosed Parkinson’s disease

  2008cited by this paper
• The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

  2008cited by this paper
• The progression of pathology in longitudinally followed patients with Parkinson’s disease

  2008influential reference
• Benign tremulous parkinsonism: A clinicopathological study

  2008cited by this paper
• Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia?

  2008cited by this paper
• Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients

  2008cited by this paper
• Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study

  2008cited by this paper
• Patients with adult‐onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)

  2007cited by this paper
• Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease

  2007cited by this paper
• The progression of Parkinson disease

  2007cited by this paper
• Patterns of levodopa response in Parkinson's disease: a clinico-pathological study.

  2007cited by this paper
• Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies

  2007cited by this paper
• Lewy Bodies in Progressive Supranuclear Palsy Represent an Independent Disease Process

  2006cited by this paper
• Benign tremulous parkinsonism.

  2006cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• Benign tremulous parkinsonism.

  2006cited by this paper
• Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies

  2006cited by this paper
• Benign tremulous parkinsonism?

  2006cited by this paper
• Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

  2005cited by this paper
• Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach

  2005influential reference
• Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?

  2005cited by this paper
• How to diagnose multiple system atrophy

  2005cited by this paper
• Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.

  2005cited by this paper
• Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

  2005cited by this paper
• [A differentiated approach to Parkinson's disease treatment in early stage of the disease].

  2004cited by this paper
• [A differentiated approach to Parkinson's disease treatment in early stage of the disease].

  2004cited by this paper
• Tremor in Parkinson’s disease and serotonergic dysfunction

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

  2003cited by this paper
• Tremor in Parkinson's disease and serotonergic dysfunction An 11 C-WAY 100635 PET study

  2003cited by this paper
• Lewy body cortical involvement may not always predict dementia in Parkinson’s disease

  2003cited by this paper
• Ten-year follow-up of three different initial treatments in de-novo PD

  2001cited by this paper
• Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study.

  2000cited by this paper
• Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis.

  2000cited by this paper
• Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease

  2000cited by this paper
• Progression of parkinsonian signs in Parkinson disease.

  1999cited by this paper
• Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?

  1999cited by this paper
• A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

  1999influential reference
• Young‐onset Parkinson's disease revisited—clinical features, natural history, and mortality

  1998cited by this paper
• Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.

  1996cited by this paper
• Prognostic significance of the onset mode in parkinsonism

  1993cited by this paper
• Isolated tremor and disruption of the nigrostriatal dopaminergic system

  1992cited by this paper
• The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease

  1991cited by this paper
• A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease

  1988cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Young onset Parkinson's disease

  1987cited by this paper
• The heterogeneity of Parkinson's disease

  1985cited by this paper
• Parkinsonism

  1967cited by this paper

• Alkaloids and flavonoids of Solanaceae: Mechanisms of action in neurodegenerative diseases.

  2026cites this paper
• Serum phosphorylated tau 217 in GBA1 variant carriers with and without Parkinson disease.

  2026cites this paper
• A deep clustering Gaussian Process algorithm for motor progression prediction of Parkinson’s disease

  2026cites this paper
• Risk factors associated with severe progression of Parkinson’s disease: random forest and logistic regression models

  2025cites this paper
• Associations of Epigenetic Age Acceleration with Motor Impairment: Evidence from the PPMI Cohort

  2025cites this paper
• White matter alterations in tremor-dominant and postural instability and gait disturbance subtypes of Parkinson’s disease

  2025influential citation
• The challenges with the identification of Parkinson’s disease subtypes

  2025cites this paper
• Prognostic Value of Parkinson's Disease Subtypes in the LABS-PD Cohort: Functional Ability, Quality of Life and Mortality.

  2025cites this paper
• A Case Report On Ayurvedic Management Of Rigidity Predominant Parkinsons Disease

  2025cites this paper
• VReeze: an open-source virtual reality for the examination of freezing of gait in Parkinson’s disease – a study design of a crossover repeated measures study for validation

  2025cites this paper
• Elevated Mean Corpuscular Hemoglobin Concentration as a Potential Peripheral Biomarker of Parkinson’s Disease: A Pilot Case–Control Study in a Mexican Population

  2025cites this paper
• The impact of cognitive impairment and Alzheimer's disease neuropathological changes on gait, freezing and falls in Parkinson's disease.

  2025cites this paper
• Microbiota–gut–brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets

  2025cites this paper
• Understanding the Pre-Clinical Stages of Parkinson’s Disease: Where Are We in Clinical and Research Settings?

  2025cites this paper
• Genetic Modifiers of Parkinson's Disease: A Case–Control Study

  2025cites this paper
• Neurochemical Mechanisms of Tremor in Parkinson’s Disease

  2025cites this paper
• Biological frameworks for Parkinson’s disease: the heterogeneity SAAgged

  2025cites this paper
• Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease

  2025cites this paper
• Tremor in Parkinson's Disease

  2025cites this paper
• Association of motor subtype and tremor type with Parkinson's disease progression: An exploratory longitudinal analysis

  2024cites this paper
• Identifying genetic targets in clinical subtypes of Parkinson’s disease for optimizing pharmacological treatment strategies

  2024cites this paper
• Brain-first forms of Parkinson's Disease are over-represented in patients with non-responsive resting tremor

  2024cites this paper
• TMS-evoked potentials unveil occipital network involvement in patients diagnosed with Parkinson’s disease within 5 years of inclusion

  2024influential citation
• Diagnostic utility of 7T neuromelanin imaging of the substantia nigra in Parkinson’s disease

  2024cites this paper
• CISL-PD: A deep learning framework of clinical intervention strategies for Parkinson's disease based on directional counterfactual Dual GANs

  2024cites this paper
• Study protocol of the HessenKohorte2042: a prospective, longitudinal cohort study characterising quality of life in people with Parkinson’s disease and their caregivers using a bio-psycho-social approach

  2024cites this paper
• Cerebellar Structural and N-Acetylaspartate, Choline, and Creatine Metabolic Profiles in Parkinson’s Disease and Essential Tremor

  2024cites this paper
• Multiparametric quantitative MRI uncovers putamen microstructural changes in Parkinson’s disease

  2024cites this paper
• Data-driven discovery of movement-linked heterogeneity in neurodegenerative diseases

  2024cites this paper
• Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells

  2024cites this paper
• Neurofilaments in neurologic disease.

  2024cites this paper
• Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same

  2024cites this paper
• Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease

  2024cites this paper
• Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes

  2024cites this paper
• Different iron distribution patterns in Parkinson's disease and its motor subtypes: a quantitative susceptibility mapping study

  2024cites this paper
• Monogenic Parkinson's Disease and the Impact of APOE E4: A Case-Control Study

  2024cites this paper
• Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease

  2024cites this paper
• Dopa-responsive Rest Tremor Preceding Tachyphemia in Progressive Supranuclear Palsy

  2024cites this paper
• Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome

  2024cites this paper
• Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis

  2023cites this paper
• Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.

  2023cites this paper
• Neuroimaging and plasma marker evidence for white matter macrostructure loss in Parkinson’s disease

  2023cites this paper
• Blood neurofilament light chain in Parkinson’s disease

  2023cites this paper
• Parkinson’s disease progression: Increasing expression of an invariant common core subnetwork

  2023cites this paper
• An Assistant Diagnosis System for Parkinson Disease Based on Mutual Information and Genetic Algorithm

  2023cites this paper
• Differences in Survival across Monogenic Forms of Parkinson's Disease

  2023cites this paper
• Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson’s disease

  2023cites this paper
• Cognitive impairment and dementia in young onset Parkinson’s disease

  2023cites this paper
• A Transdiagnostic Structural Brain Signature of Parkinsonian and Essential Tremor

  2023cites this paper
• Cerebral cortical thinning in Parkinson’s disease depends on the age of onset

  2023cites this paper
• Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease

  2023cites this paper
• Nanotechnology-Based Drug Delivery For Alzheimer's And Parkinson's Diseases.

  2023cites this paper
• Regional homogeneity and functional connectivity of freezing of gait conversion in Parkinson’s disease

  2023cites this paper
• A progression analysis of motor features in Parkinson's disease based on the mapper algorithm

  2023cites this paper
• Autonomic function and motor subtypes in Parkinson’s disease: a multicentre cross-sectional study

  2023cites this paper
• Refining the diagnostic accuracy of Parkinsonian disorders using metaphenomic annotation of the clinicopathological literature

  2023cites this paper
• Remote scoring models of rigidity and postural stability of Parkinson’s disease based on indirect motions and a low-cost RGB algorithm

  2023cites this paper
• Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study

  2023cites this paper
• Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin

  2023cites this paper
• Clinical subtypes in patients with isolated REM sleep behaviour disorder

  2023cites this paper
• Utility of Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Diagnostic Biomarkers of Freezing of Gait in Parkinson's Disease.

  2023cites this paper
• Apolipoprotein D concentration in Parkinson’s disease patients

  2023cites this paper
• Monoaminergic Degeneration and Ocular Motor Abnormalities in De Novo Parkinson's Disease

  2023cites this paper
• Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson’s disease subtypes

  2023cites this paper
• Role of rodent models in advancing precision medicine for Parkinson's disease.

  2023cites this paper
• Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers.

  2022cites this paper
• Anosmia in Parkinson’s Disease in Pakistan: A Matched Case – Control Study

  2022cites this paper
• Gray and white matter alterations in different predominant side and type of motor symptom in Parkinson's disease

  2022cites this paper
• Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism

  2022cites this paper
• Morphological basis of Parkinson disease-associated cognitive impairment: an update

  2022cites this paper
• Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism

  2022cites this paper
• Pathophysiology and Symptomatology of Drooling in Parkinson’s Disease

  2022cites this paper
• Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.

  2022cites this paper
• Neuropathological changes in advanced Parkinson’s disease

  2022cites this paper
• Data-Driven Subtyping of Parkinson’s Using Acoustic Analysis of Sustained Vowels and Cluster Analysis: Findings in the Parkinson’s Voice Initiative Study

  2022cites this paper
• Nigral neuropathology of Parkinson’s motor subtypes coincide with circuitopathies: a scoping review

  2022cites this paper
• Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients

  2022cites this paper
• Parkinson’s Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation

  2022cites this paper
• Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson’s disease in the MARK-PD study

  2022cites this paper
• Neuropathological substrates of cognition in Parkinson's disease.

  2022cites this paper
• Efficacy of caudal pedunculopontine nucleus stimulation on postural instability and gait disorders in Parkinson’s disease

  2022cites this paper
• The pathophysiology of Parkinson's disease tremor.

  2022cites this paper
• Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease

  2022cites this paper
• How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review

  2022cites this paper
• Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model

  2022cites this paper
• Differences in neuroanatomy and functional connectivity between motor subtypes of Parkinson’s disease

  2022cites this paper
• Pharmacological management of Parkinson’s disease motor symptoms: update and recommendations from an expert

  2022cites this paper
• Challenges in the diagnosis of Parkinson's disease.

  2021cites this paper
• Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes

  2021cites this paper
• Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations

  2021cites this paper
• Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models

  2021cites this paper
• RECENT TRENDS IN THE TREATMENT OF PARKINSON'S DISEASE

  2021cites this paper
• Prevalence and Clinical Features of FOG in Chinese PD Patients, a Multicenter and Cross-Sectional Clinical Study

  2021cites this paper
• Autonomic Dysfunction in Parasomnias of REM Sleep

  2021cites this paper
• Cortical thickness in Parkinson's disease: a coordinate-based meta-analysis

  2021cites this paper
• Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers

  2021cites this paper
• Clinical features associated with drooling in Parkinson’s disease

  2021cites this paper
• Antioxidative role of Traditional Chinese Medicine in Parkinson's disease.

  2021cites this paper
• Progression of Self-Perceived Speech and Swallowing Impairment in Early Stage Parkinson's Disease: Longitudinal Analysis of the Unified Parkinson's Disease Rating Scale.

  2021cites this paper
• Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 study.

  2021cites this paper